Human Molecular Genetics, 2002, Vol. 11, No. 18 2103-2111
© 2002 Oxford University Press
A mouse model of spinal and bulbar muscular atrophy

1Monash Institute of Reproduction and Development, Monash University, 2731 Wright Street, Clayton, Melbourne, Victoria, 3168, Australia, 2Neurosciences Group, Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton, Melbourne, Victoria, 3168, Australia and 3Department of Anatomy and Cell Biology, Monash University, Clayton, Melbourne, Victoria, 3168, Australia
Received April 11, 2002; Revised June 20, 2002; Accepted June 24, 2002
Spinal and bulbar muscular atrophy (SBMA) is an adult-onset motor neuron disease, caused by the expansion of a trinucleotide repeat (TNR) in exon 1 of the androgen receptor (AR) gene. This disorder is characterized by degeneration of motor and sensory neurons, proximal muscular atrophy, and endocrine abnormalities, such as gynecomastia and reduced fertility. We describe the development of a transgenic model of SBMA expressing a full-length human AR (hAR) cDNA carrying 65 (AR65) or 120 CAG repeats (AR120), with widespread expression driven by the cytomegalovirus promoter. Mice carrying the AR120 transgene displayed behavioral and motor dysfunction, while mice carrying 65 CAG repeats showed a mild phenotype. Progressive muscle weakness and atrophy was observed in AR120 mice and was associated with the loss of
-motor neurons in the spinal cord. There was no evidence of neurodegeneration in other brain structures. Motor dysfunction was observed in both male and female animals, showing that in SBMA the polyglutamine repeat expansion causes a dominant gain-of-function mutation in the AR. The male mice displayed a progressive reduction in sperm production consistent with testis defects reported in human patients. These mice represent the first model to reproduce the key features of SBMA, making them a useful resource for characterizing disease progression, and for testing therapeutic strategies for both polyglutamine and motor neuron diseases.
* To whom correspondence should be addressed Tel: +61 395947128; Fax: +61 395947111; E-mail: john.morrison@med.monash.edu.au
Present address: Pharmacia Corporation, 4901 Searle Parkway, Skokje, Illinois 60077, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. R. Goldman-Johnson, D. M. de Kretser, and J. R. Morrison Evidence that Androgens Regulate Early Developmental Events, Prior to Sexual Differentiation Endocrinology, January 1, 2008; 149(1): 5 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Monks, J. A. Johansen, K. Mo, P. Rao, B. Eagleson, Z. Yu, A. P. Lieberman, S. M. Breedlove, and C. L. Jordan Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease PNAS, November 13, 2007; 104(46): 18259 - 18264. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Siwach, S. D. Pophaly, and S. Ganesh Genomic and Evolutionary Insights into Genes Encoding Proteins with Single Amino Acid Repeats Mol. Biol. Evol., July 1, 2006; 23(7): 1357 - 1369. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yu, N. Dadgar, M. Albertelli, A. Scheller, R. L. Albin, D. M. Robins, and A. P. Lieberman Abnormalities of Germ Cell Maturation and Sertoli Cell Cytoskeleton in Androgen Receptor 113 CAG Knock-In Mice Reveal Toxic Effects of the Mutant Protein Am. J. Pathol., January 1, 2006; 168(1): 195 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thomas, Z. Yu, N. Dadgar, S. Varambally, J. Yu, A. M. Chinnaiyan, and A. P. Lieberman The Unfolded Protein Response Modulates Toxicity of the Expanded Glutamine Androgen Receptor J. Biol. Chem., June 3, 2005; 280(22): 21264 - 21271. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Everett and N. W. Wood Trinucleotide repeats and neurodegenerative disease Brain, November 1, 2004; 127(11): 2385 - 2405. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Chevalier-Larsen, C. J. O'Brien, H. Wang, S. C. Jenkins, L. Holder, A. P. Lieberman, and D. E. Merry Castration Restores Function and Neurofilament Alterations of Aged Symptomatic Males in a Transgenic Mouse Model of Spinal and Bulbar Muscular Atrophy J. Neurosci., May 19, 2004; 24(20): 4778 - 4786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Michalik and C. Van Broeckhoven Pathogenesis of polyglutamine disorders: aggregation revisited Hum. Mol. Genet., October 15, 2003; 12(90002): R173 - 186. [Abstract] [Full Text] [PDF] |
||||







